Rite Aid Remains On Track Despite Projected Q4 EBITDA Miss

The Sound of Money
366 Followers

Summary

  • Deutsche Bank raises price target on RAD to $27.
  • US government increases vaccine reimbursement from $28 to $40 per dose.
  • RAD will benefit from a significantly more dramatic cold/flu season in 2021-2022.
Young woman getting vaccinated
Photo by Marko Geber/DigitalVision via Getty Images

Management Updates Guidance

On March 25, 2021, Rite Aid provided updated guidance (press release) for the 2021 fiscal year that closed on February 27, 2021. In that guidance, Rite Aid indicated the following:

  • Full year revenue of approximately $24 billion (on target

This article was written by

366 Followers
I am a consultant with a PhD and background in securities, insurance, and education. My securities background includes stock and options trading for over twenty years, econometric modeling, and the completion of the Chartered Financial Consultant designation (ChFC). My insurance work and training includes estate planning, life insurance sales, and the completion of the Chartered Life Underwriter designation (CLU).

Analyst’s Disclosure:I am/we are long RAD. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About RADCQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on RADCQ

Related Stocks

SymbolLast Price% Chg
RADCQ
--